IP Library Granted Patent US 7,696,343
Granted Patent B2
US 7,696,343 · App. 11/624,630 · Granted Apr 13, 2010

Method for opening tight junctions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,696,343
App. No.
11/624,630
Granted
Apr 13, 2010
Kind
B2
Abstract

The use of antagonists to JAM-1 Claudin-4 and occludin to open tight junctions. The antagonists include, by way of example antibodies and antibody fragments that bind to the proteins and small interfering nucleic acids that downregulate the mRNA encoding the proteins.

Claims (6)

1. A small interfering nucleic acid (siNA) that down-regulates the expression of a junctional adhesion molecule-1 (JAM-1) mRNA, the siNA comprising a sense strand, an antisense strand having at least 19 nucleotides, and a duplex region, wherein the nucleotide sequence of the antisense strand comprises SEQ ID NO:51.

2. The siNA of claim 1 , wherein the duplex region has at least 19 base pairs.

3. The siNA of claim 1 , wherein the sense strand and antisense strand each independently have from about 19 to about 1 nucleotides.

4. The siNA of claim 1 , wherein the siNA has a 5′-cap and/or 3′-cap structure.

5. The siNA of claim 1 , wherein the siNA has at least one 3′ overhang.

6. The siNA of claim 1 , wherein the siNA down-regulates the expression of a junctional adhesion molecule-1 (JAM-1) rnRNA in a respiratory epithelial cell.

Assignments (1)
RELEASE OF SECURITY INTEREST Recorded Apr 14, 2014
From: GENESIS CAPITAL MANAGEMENT, LLC, AS AGENT
To: MARINA BIOTECH, INC.; CEQUENT PHARMACEUTICALS, INC.; MDRNA RESEARCH, INC.
Reel/Frame 032685/0158 →